BOSTON, Jan. 3, 2025 /PRNewswire/ — Later, a leader in influencer marketing and social media management software and services, today…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Chipotle Mexican Grill, Inc. (“Chipotle” or…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Symbotic Inc. (“Symbotic” or the “Company”)…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Nextracker Inc. (“Nextracker” or the “Company”)…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. (“Cassava Sciences, Inc.”…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. (“Applied Therapeutics” or…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. (“ASP Isotopes Inc.”…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Aehr Test Systems, Inc. (“Aehr” or…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. (“Dentsply” or the…
Read MoreNEW YORK, Jan. 3, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.”…
Read MoreWe use cookies to improve your experience. You can choose which types of cookies to accept. Read our Privacy Policy.
Choose which cookies to enable:
PRNewswire